Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 2/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.89 |
| ▸ | GAA | P10253 | 1/20 | 0.89 |
| ▸ | HRH3 | Q9Y5N1 | 18/20 | 0.85 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29761972 | 0.94 | SLC1A2 (1.00) | SLC1A2ALDH1A1GAAHRH3SLC1A3 | |
| SCHEMBL4020966 | 0.92 | HRH3 (1.00) | HRH3CYP2D6 | |
| SCHEMBL4025332 | 0.91 | HRH3 (0.89) | HRH3CYP3A4CYP2D6 | |
| SCHEMBL4021536 | 0.87 | HRH3 (0.80) | HRH3CYP2D6 | |
| SCHEMBL29761986 | 0.87 | SLC1A2 (0.89) | SLC1A2ALDH1A1GAAHRH3SLC1A3 | |
| SCHEMBL4019208 | 0.87 | HRH3 (0.82) | HRH3CYP2D6 | |
| SCHEMBL4020046 | 0.87 | HRH3 (1.00) | HRH3CYP2D6 | |
| SCHEMBL4193300 | 0.86 | HRH3 (0.78) | HRH3CYP2D6 | |
| SCHEMBL4019973 | 0.86 | HRH3 (0.80) | SLC1A2ALDH1A1GAAHRH3CYP3A4 | |
| SCHEMBL4185684 | 0.86 | HRH3 (0.78) | HRH3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009095394-A1 | DIAZEPANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS | EVOTEC NEUROSCIENCES GMBH (DE) | 2009-08-06 | — | — | WO | claimed |
| WO-2009095394-A1 | DIAZEPANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS | EVOTEC NEUROSCIENCES GMBH (DE) | 2009-08-06 | — | — | WO | disclosed |